Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non–Small Cell Lung Cancer

S Guan, X Chen, Y Wei, F Wang, W Xie, Y Chen… - Clinical Cancer …, 2024 - AACR
Purpose: Although somatic mutations were explored in depth, limited biomarkers were found
to predict the resistance of EGFR tyrosine kinase inhibitors (EGFR-TKI). Previous studies …
相关文章

Germline USP36 mutation confers resistance to EGFR-TKIs by upregulating MLLT3 expression in non-small cell lung cancer patients.

S Guan, X Chen, Y Wei, F Wang, W Xie… - … Cancer Research: an …, 2024 - europepmc.org
Although somatic mutations were explored in depth, limited biomarkers were found to
predict the resistance of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR …

Germline USP36 mutation confers resistance to EGFR-TKIs by upregulating MLLT3 expression in non-small cell lung cancer patients

S Guan, X Chen, Y Wei, F Wang, W Xie… - … cancer research: an … - pubmed.ncbi.nlm.nih.gov
Purpose Although somatic mutations were explored in depth, limited biomarkers were found
to predict the resistance of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR …